Under its Framework Six funding programme, this new European Union initiative aims to translate medical research results into clinical trials in developing countries, particularly in Africa. The first move is to provide 200 million Euros for the development of new medicines and vaccines for HIV/AIDS, malaria and tuberculosis. The website contains a general outline of this scheme and information about its projects.


Related topics